Literature DB >> 15804705

Anti-Sm and anti-RNP antibodies.

P Migliorini1, C Baldini, V Rocchi, S Bombardieri.   

Abstract

Among anti-nuclear antibodies, anti-Sm and anti-RNP antibodies are of the utmost importance in clinical practice. Anti-Sm antibodies are directed against 7 proteins (B/B', D1, D2, D3, E, F, G) that constitute the common core of U1, U2, U4 and U5 small nuclear ribonucleoprotein (snRNP) particles; B/B', D1 and D3 are more frequently targeted. Anti-RNP antibodies react with proteins (70 Kd, A, C) that are associated with U1 RNA and form U1snRNP. Anti-Sm and anti-RNP antibodies are directed towards both discontinuous and linear epitopes which are either contained in the protein sequence or are post-translationally modified. The assays to detect anti-Sm and anti-RNP antibodies are counterimmunoelectrophoresis (CIE), immunoblot, and ELISA, based on purified or recombinant proteins or synthetic peptides. Anti-Sm antibodies are detectable in a percentage of SLE patients comprised between 5 and 30%; they are more prevalent in blacks and because of their high specificity for SLE have been included in the serological criteria for diagnosing the disease.Anti-RNP are detectable in 25-47% of SLE patients; high titers of anti-RNP antibodies are diagnostic of mixed connective tissue disorder (MCTD). The measurement of anti-Sm and anti-RNP antibodies is more important in the diagnosis of SLE than in the follow-up of patients. However, anti-RNP antibodies are more prevalent in patients with Raynaud's phenomenon and are associated with milder renal involvement. On the contrary, anti-Sm antibodies are associated with the severity and the activity of renal involvement. The specificity of anti-Sm antibodies, together with epidemiological data, suggest that Epstein-Barr virus infection has the potential to induce anti-Sm antibodies by molecular mimicry.Anti-nuclear antibodies, a hallmark of the systemic autoimmune diseases, include several populations of antibodies with different specificities. Among them, anti-Sm and anti-RNP antibodies are of the utmost importance in clinical practice; in research, the study of the mechanisms inducing their production has opened up new perspectives and helped to elucidate the pathogenesis of autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804705     DOI: 10.1080/08916930400022715

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  58 in total

Review 1.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

2.  Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus.

Authors:  Sung Soo Ahn; Seung Min Jung; Juyoung Yoo; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

Review 3.  The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.

Authors:  Alina Dima; Ciprian Jurcut; Cristian Baicus
Journal:  Rheumatol Int       Date:  2018-05-23       Impact factor: 2.631

4.  Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.

Authors:  Q-Z Li; J Zhou; A E Wandstrat; F Carr-Johnson; V Branch; D R Karp; C Mohan; E K Wakeland; N J Olsen
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

5.  Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.

Authors:  Xiaozhen Zhao; Yongjing Cheng; Yuzhou Gan; Rulin Jia; Lei Zhu; Xiaolin Sun
Journal:  Clin Rheumatol       Date:  2018-02-09       Impact factor: 2.980

6.  Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.

Authors:  Deborah Kienhöfer; Jonas Hahn; Julia Stoof; Janka Zsófia Csepregi; Christiane Reinwald; Vilma Urbonaviciute; Caroline Johnsson; Christian Maueröder; Malgorzata J Podolska; Mona H Biermann; Moritz Leppkes; Thomas Harrer; Malin Hultqvist; Peter Olofsson; Luis E Munoz; Attila Mocsai; Martin Herrmann; Georg Schett; Rikard Holmdahl; Markus H Hoffmann
Journal:  JCI Insight       Date:  2017-05-18

7.  The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.

Authors:  T Hung; G A Pratt; B Sundararaman; M J Townsend; C Chaivorapol; T Bhangale; R R Graham; W Ortmann; L A Criswell; G W Yeo; T W Behrens
Journal:  Science       Date:  2015-09-17       Impact factor: 47.728

8.  B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice.

Authors:  Sun-Hee Hwang; Huiyin Lee; Miwako Yamamoto; Leigh A Jones; Jivanaah Dayalan; Richard Hopkins; Xin J Zhou; Felix Yarovinsky; John E Connolly; Maria A Curotto de Lafaille; Edward K Wakeland; Anna-Marie Fairhurst
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

Review 9.  Granzyme B cleavage of autoantigens in autoimmunity.

Authors:  E Darrah; A Rosen
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

10.  Systemic lupus erythematosus and Raynaud's phenomenon.

Authors:  Flavia Emilie Heimovski; Juliana A Simioni; Thelma Larocca Skare
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.